StockClub

SUPN

SUPNSupernus Pharmaceuticals, Inc.$ --
Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc.

SUPN

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
212M USD
YoY +21.5%
Operating Income
14M USD
YoY -35.4%
Net Income
-4M USD
YoY -126.8%
EPS
-0.07$
YoY -125.6%

Revenue

$719M
FY2024 Q1$143.6M
$143.6M
Q1
FY2024 Q2$312M
$312M
Q2
FY2024 Q3$487.7M
$487.7M
Q3
FY2024 Q4$661.8M
$661.8M
Q4
FY2025 Q1$149.8M
$149.8M
Q1
FY2025 Q2$315.3M
$315.3M
Q2
FY2025 Q3$507.4M
$507.4M
Q3
FY2025 Q4$719M
$719M
Q4
Actual
+$57.1M (+8.6%)

Net Income

$-38.5M
FY2024 Q1$124,000
$124,000
Q1
FY2024 Q2$20M
$20M
Q2
FY2024 Q3$58.5M
$58.5M
Q3
FY2024 Q4$73.9M
$73.9M
Q4
FY2025 Q1$-11.8M
$-11.8M
Q1
FY2025 Q2$10.7M
$10.7M
Q2
FY2025 Q3$-34.4M
$-34.4M
Q3
FY2025 Q4$-38.5M
$-38.5M
Q4
Actual
$-112.4M (-152.2%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$520.4M
Est:$523M
FY2020MISS
$520.4M
FY2021MISS
Actual:$579.8M
Est:$579.8M
FY2021MISS
$579.8M
FY2022MISS
Actual:$667.2M
Est:$680.3M
FY2022MISS
$667.2M
FY2023MISS
Actual:$607.5M
Est:$630.2M
FY2023MISS
$607.5M
FY2024BEAT
Actual:$661.8M
Est:$642.9M
FY2024BEAT
$661.8M
FY2025BEAT
Actual:$719M
Est:$702.5M
FY2025BEAT
$719M

Analyst Estimates